Overview Dividends

(ARMK) Aramark Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03852U1060

Food Services, Facilities Services, Catering, Vending, Custodial

ARMK EPS (Earnings per Share)

EPS Growth (3Y CAGR): -6.41%
EPS Trend (3Y Correlation): 0.1%

ARMK Revenue

Revenue Growth (3Y CAGR): 1.92%
Revenue Trend (3Y Correlation): 46.7%

Description: ARMK Aramark Holdings October 30, 2025

Aramark Holdings (NYSE: ARMK) delivers food and facilities services across education, healthcare, business & industry, sports & leisure, and corrections markets in the United States and abroad, organized into two reporting segments: Food & Support Services U.S. and Food & Support Services International.

The company’s portfolio includes managed dining, catering, and retail food operations; non-clinical patient nutrition and environmental services; and a suite of facility-management offerings such as custodial, energy management, grounds keeping, and capital-project oversight. It also runs on-site restaurants, vending, concessions, and hospitality services for sports and entertainment venues, plus correctional food, commissaries, and laundry facilities.

Key recent metrics: FY 2023 revenue of $15.4 billion, adjusted EBITDA margin of roughly 7 %, and a contract backlog of about $3.5 billion, indicating a solid pipeline. The business is sensitive to macro drivers such as institutional food-service demand, labor-cost inflation, and commodity price volatility, while the shift toward outsourced non-core services in hospitals and universities supports top-line growth.

For a deeper, data-driven assessment of ARMK’s valuation and risk profile, the ValueRay platform provides a comprehensive dashboard for further research.

ARMK Stock Overview

Market Cap in USD	10,193m
Sub-Industry	Restaurants
IPO / Inception	2013-12-12

ARMK Stock Ratings

Growth Rating	46.7%
Fundamental	50.3%
Dividend Rating	53.4%
Return 12m vs S&P 500	-16.3%
Analyst Rating	4.43 of 5

ARMK Dividends

Dividend Yield 12m	1.12%
Yield on Cost 5y	1.76%
Annual Growth 5y	5.23%
Payout Consistency	98.8%
Payout Ratio	33.6%

ARMK Growth Ratios

Growth Correlation 3m	-23.6%
Growth Correlation 12m	30.4%
Growth Correlation 5y	81.6%
CAGR 5y	12.14%
CAGR/Max DD 3y (Calmar Ratio)	0.44
CAGR/Mean DD 3y (Pain Ratio)	1.31
Sharpe Ratio 12m	0.31
Alpha	-24.28
Beta	1.287
Volatility	24.41%
Current Volume	1433.7k
Average Volume 20d	2228.7k
Stop Loss	36.2 (-3.2%)
Signal	0.18

Piotroski VR‑10 (Strict, 0-10) 1.5

Net Income (361.7m TTM) > 0 and > 6% of Revenue (6% = 1.07b TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA -0.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 4.42% (prev -0.69%; Δ 5.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 767.1m > Net Income 361.7m (YES >=105%, WARN >=100%)

Net Debt (6.11b) to EBITDA (1.31b) ratio: 4.68 <= 3.0 (WARN <= 3.5)

Current Ratio 1.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (267.2m) change vs 12m ago 0.23% (target <= -2.0% for YES)

Gross Margin 8.55% (prev 8.66%; Δ -0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 138.4% (prev 142.5%; Δ -4.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.50 (EBITDA TTM 1.31b / Interest Expense TTM 336.2m) >= 6 (WARN >= 3)

Altman Z'' 0.95

(A) 0.06 = (Total Current Assets 3.53b - Total Current Liabilities 2.74b) / Total Assets 13.28b

(B) 0.03 = Retained Earnings (Balance) 393.7m / Total Assets 13.28b

(D) 0.02 = Book Value of Equity 245.1m / Total Liabilities 10.19b

Total Rating: 0.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 50.34

1. Piotroski 1.50pt = -3.50

2. FCF Yield 1.72% = 0.86

3. FCF Margin 1.57% = 0.39

4. Debt/Equity 2.14 = 0.55

5. Debt/Ebitda 4.68 = -2.50

6. ROIC - WACC (= 0.03)% = 0.04

7. RoE 11.83% = 0.99

8. Rev. Trend 46.73% = 3.50

9. EPS Trend 0.06% = 0.00

What is the price of ARMK shares?

As of November 07, 2025, the stock is trading at USD 37.38 with a total of 1,433,655 shares traded.
Over the past week, the price has changed by -3.61%, over one month by -4.15%, over three months by -5.05% and over the past year by -3.86%.

Is Aramark Holdings a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Aramark Holdings is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 50.34 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ARMK is around 37.02 USD . This means that ARMK is currently overvalued and has a potential downside of -0.96%.

Is ARMK a buy, sell or hold?

Aramark Holdings has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy ARMK.

Strong Buy: 8
Buy: 4
Hold: 2
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ARMK price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	45	20.3%
Analysts Target Price	45	20.3%
ValueRay Target Price	40.7	8.8%

ARMK Fundamental Data Overview November 01, 2025

Market Cap USD = 10.19b (10.19b USD * 1.0 USD.USD)
P/E Trailing = 28.5147
P/E Forward = 17.6991
P/S = 0.5703
P/B = 3.2821
P/EG = 0.6993
Beta = 1.287
Revenue TTM = 17.87b USD
EBIT TTM = 840.4m USD
EBITDA TTM = 1.31b USD
Long Term Debt = 6.25b USD (from longTermDebt, last quarter)
Short Term Debt = 101.7m USD (from shortTermDebt, last quarter)
Debt = 6.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.11b USD (from netDebt column, last quarter)
Enterprise Value = 16.31b USD (10.19b + Debt 6.62b - CCE 501.5m)
Interest Coverage Ratio = 2.50 (Ebit TTM 840.4m / Interest Expense TTM 336.2m)
FCF Yield = 1.72% (FCF TTM 280.8m / Enterprise Value 16.31b)
FCF Margin = 1.57% (FCF TTM 280.8m / Revenue TTM 17.87b)
Net Margin = 2.02% (Net Income TTM 361.7m / Revenue TTM 17.87b)
Gross Margin = 8.55% ((Revenue TTM 17.87b - Cost of Revenue TTM 16.35b) / Revenue TTM)
Gross Margin QoQ = 8.00% (prev 8.40%)
Tobins Q-Ratio = 1.23 (Enterprise Value 16.31b / Total Assets 13.28b)
Interest Expense / Debt = 1.31% (Interest Expense 86.4m / Debt 6.62b)
Taxrate = 25.19% (24.2m / 96.2m)
NOPAT = 628.6m (EBIT 840.4m * (1 - 25.19%))
Current Ratio = 1.29 (Total Current Assets 3.53b / Total Current Liabilities 2.74b)
Debt / Equity = 2.14 (Debt 6.62b / totalStockholderEquity, last quarter 3.08b)
Debt / EBITDA = 4.68 (Net Debt 6.11b / EBITDA 1.31b)
Debt / FCF = 21.78 (Net Debt 6.11b / FCF TTM 280.8m)
Total Stockholder Equity = 3.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.72% (Net Income 361.7m / Total Assets 13.28b)
RoE = 11.83% (Net Income TTM 361.7m / Total Stockholder Equity 3.06b)
RoCE = 9.03% (EBIT 840.4m / Capital Employed (Equity 3.06b + L.T.Debt 6.25b))
RoIC = 6.94% (NOPAT 628.6m / Invested Capital 9.06b)
WACC = 6.91% (E(10.19b)/V(16.81b) * Re(10.76%) + D(6.62b)/V(16.81b) * Rd(1.31%) * (1-Tc(0.25)))
Discount Rate = 10.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.55%
[DCF Debug] Terminal Value 70.81% ; FCFE base≈301.4m ; Y1≈333.2m ; Y5≈432.1m
Fair Price DCF = 18.49 (DCF Value 4.86b / Shares Outstanding 262.9m; 5y FCF grow 12.14% → 3.0% )
EPS Correlation: 0.06 | EPS CAGR: -6.41% | SUE: 0.0 | # QB: 0
Revenue Correlation: 46.73 | Revenue CAGR: 1.92% | SUE: -0.04 | # QB: 0

Additional Sources for ARMK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle